Trump says RFK Jr. free to revisit discredited autism/vaccine link
If Robert F. Kennedy Jr. is approved to head the U.S. Department of Health and Human Services, he will be free to revisit a long-debunked link between autism and childhood vaccines, President-elect Donald Trump said Sunday.
8 hours ago
0
0
Minnesota reports highest level of whooping cough cases in more than a decade
Minnesota is reporting the highest number of whooping cough cases in more than a decade, the state Department of Health says.
Dec 9, 2024
0
0
Expert explains shingles and the shingles vaccine
Shingles can strike anyone who had chickenpox when they were young, and the intense pain that can accompany this body rash has sidelined many a senior.
Dec 9, 2024
0
0
Nursing homes fell behind on vaccinating patients for COVID, study finds
It seems no one is taking COVID-19 seriously anymore, said Mollee Loveland, a nursing home aide who lives outside Pittsburgh.
Dec 9, 2024
0
0
Rotavirus vaccine is safe for use in NICU babies, researchers find
Researchers from Children's Hospital of Philadelphia (CHOP) found that transmission of rotavirus vaccine strains in a neonatal intensive care unit (NICU) is rare and without clinical consequences, strongly suggesting that ...
Dec 9, 2024
0
0
How measles, whooping cough, and worse could roar back
The availability of safe, effective COVID vaccines less than a year into the pandemic marked a high point in the 300-year history of vaccination, seemingly heralding an age of protection against infectious diseases.
Dec 9, 2024
0
0
Measles case reported at Los Angeles International Airport, Orange County children's hospital: Who is at risk?
Health officials warned Thursday that people who were at Los Angeles International Airport and Children's Hospital of Orange County in recent days may have been exposed to measles.
Dec 9, 2024
0
0
Broadly effective vaccine design offers new hope in the fight against hepatitis C
The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due to the high genetic diversity of the virus. A research team has now achieved promising results. ...
Dec 6, 2024
0
45
Possible colon cancer vaccine target uncovered in bacteria
Higher rates of certain cancers in countries, such as the UK, may be linked to two particular strains of bacteria. Targeting these with treatments or vaccines could help reduce the risk of colorectal, bladder, and prostate ...
Dec 5, 2024
0
5
Vaccination software tool shown to boost uptake of MMR vaccine in children in UK
A software tool developed by Queen Mary University of London's Clinical Effectiveness Group (CEG) and used as part of a facilitated quality improvement program has increased the number of children receiving their first MMR ...
Dec 5, 2024
0
0
Sierra Leone begins nationwide rollout of Ebola vaccine a decade after deadly outbreak
Authorities in Sierra Leone on Thursday started a nationwide rollout of the single-dose Ebola vaccine, the first such campaign in West Africa where a deadly outbreak 10 years ago resulted in the death of thousands.
Dec 5, 2024
0
0
Vaccine hesitancy: Why some individuals believe fake news and conspiracies
People who are credulous are less capable of recognizing fake news, and along with mistrustful adults, are more susceptible to conspiracy thinking and vaccine hesitancy, according to a study published December 4, 2024, in ...
Dec 4, 2024
2
22
Large, real world, multistate study finds COVID-19 vaccine cuts risk of disease when administered during pregnancy
A large multistate study, conducted by the Centers for Disease Control and Prevention's (CDC's) VISION Network, has found that COVID-19 vaccination given during pregnancy offered 52% protection, cutting risk of a COVID-19-associated ...
Dec 4, 2024
0
19
New antibody discovery offers hope against evolving SARS-CoV-2 variants
Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 variants, including the elusive omicron subvariants. This antibody, named K4-66, was isolated from ...
Dec 2, 2024
0
47
Pediatrician explains whooping cough
Whooping cough, or pertussis, is a highly contagious respiratory infection caused by bacteria called Bordetella pertussis. The infection attacks the lining of the breathing passages. People can get whooping cough any time ...
Dec 2, 2024
0
0
Vaccines can put an end to HIV. African governments must take the lead in developing them
HIV remains a major global public health challenge.
Dec 2, 2024
0
0
Best time for COVID-19 booster depends on where you live, infection history
A one-size-fits-all approach for scheduling COVID-19 booster shots may not be the most effective, according to a new study by researchers at the Yale School of Public Health (YSPH) and University of North Carolina at Charlotte ...
Nov 29, 2024
0
44
New 'how-to guide' for future rapid vaccine development
Until recently, human vaccine development has typically taken 10 to 15 years.
Nov 29, 2024
0
0
Report: Flu, RSV trending upward and COVID remains flat as holiday season arrives
Coronavirus cases have been flat locally, likely due to the outsized surge that occurred this past summer, but the flu appears to be ramping up on its traditional trajectory, indicating that the latest spike of cases will ...
Nov 29, 2024
0
1
Flu vaccine estimated to be 21% effective against flu spread to household members
A study of 700 people who tested positive for influenza suggests that their risk of infecting household contacts was 18.8% and that the estimated effectiveness of flu vaccines against secondary infections is 21.0%.
Nov 27, 2024
1
40
Offering HPV vaccination to people past their mid-20s is unlikely to be cost-effective
A modeling study projected that HPV vaccination programs for adults aged 27 to 45 years could benefit subgroups at higher risk for HPV, but overall, the approach is more costly and less effective than vaccinating younger ...
Nov 26, 2024
0
0
New malaria vaccine shows high protection in clinical trial
Researchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands have demonstrated promising safety and efficacy of a late-liver-stage attenuated malaria parasite vaccine in a small ...
Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics.
Nov 25, 2024
0
0